EcoDrugPlus

Integrin, Beta 1a

Ensembl ID : ENSOKIG00005041004
Gene Symbol: ITGB1A
1 Cross references
209 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSOKIG00005005816
Gene Symbol: ITGB5
1 Cross references
204 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSOKIG00005035877
Gene Symbol: IRAK4
3 Cross references
200 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSOKIG00005018433
Gene Symbol: LOC109899930
3 Cross references
201 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSOKIG00005011838
Gene Symbol: LOC109870508
3 Cross references
201 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOKIG00005019136
Gene Symbol: IDH2
1 Cross references
201 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOKIG00005028164
Gene Symbol: IDH2
3 Cross references
185 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOKIG00005009211
Gene Symbol: IDH2
3 Cross references
200 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSOKIG00005033249
Gene Symbol: IDH2
3 Cross references
185 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp] Cytoplasmic

Ensembl ID : ENSOKIG00005048897
Gene Symbol: LOC109867781
3 Cross references
227 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp] Cytoplasmic-Like

Ensembl ID : ENSOKIG00005024323
Gene Symbol: LOC109881709
3 Cross references
228 Possible Orthologues:

Isotocin Receptor

Ensembl ID : ENSOKIG00005016495
Gene Symbol: LOC109903631
3 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).